Per ulteriori informazioni selezionare i riferimenti di interesse.
Monoclonal antibody therapy with Edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells inbone marrow
CLINICAL CANCER RESEARCH
Tumor-antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease
INTERNATIONAL JOURNAL OF CANCER
EVALUATION OF BONE-MARROW MICROMETASTASES AS POTENTIAL SURROGATE MARKER FOR EFFICACY OF ADJUVANT TREATMENT
European journal of cancer
REDUCTION OF MICROMETASTATIC TUMOR LOAD BY MONOCLONAL-ANTIBODY THERAPY - INFLUENCE OF TUMOR-ANTIGEN HETEROGENEITY
Annals of oncology
HETEROGENEOUS EXPRESSION OF TUMOR-ANTIGENS ON MICROMETASTATIC BREAST-CANCER CELLS - IMPLICATIONS FOR GENETIC APPROACHES OF CANCER-IMMUNOTHERAPY
Blood